TNON

NASDAQ

Tenon Medical Inc.

SectorHealth CareIndustryMedical/Dental InstrumentsIPO2022

News25/Ratings0

Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. It focuses on sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico. The company was incorporated in 2012 and is based in Los Gatos, California.

News · 26 weeks38-100%

2025-10-262026-04-19

Mix1490d

SEC Filings7(50%)
Market5(36%)
Insider1(7%)
Offering1(7%)

Latest news

25 items

27dSEC
SEC Form 10-K filed by Tenon Medical Inc.
10-K - Tenon Medical, Inc. (0001560293) (Filer)
35dSEC
Tenon Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - Tenon Medical, Inc. (0001560293) (Filer)
35dNEWS
Tenon(R) Medical Reports Fourth Quarter and Full Year 2025 Financial Results
~ Fourth Quarter 2025 Revenue of $1.5 Million, a 92% Increase Compared to Prior Year ~~ Record Full Year 2025 Revenue of $3.9 Million, a 20% Increase compared to Prior Year, Driven by Strong Second Half Momentum ~~ Record Full Year 2025 Gross Profit of $2.4 Million, a 38% Increase Compared to Prior Year ~~ Secured FDA 510(k) Clearance For its Next-Generation SImmetry®+ SI Joint Fusion System ~~ Completed Initial SImmetry®+ Procedures at Centers of Excellence, Advancing Commercial Rollout and Supporting Early Surgeon Adoption ~LOS GATOS, CA / ACCESS Newswire / March 19, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a company redefining care for patients sufferin
35dSEC
Amendment: SEC Form D/A filed by Tenon Medical Inc.
D/A - Tenon Medical, Inc. (0001560293) (Filer)
37dSEC
SEC Form D filed by Tenon Medical Inc.
D - Tenon Medical, Inc. (0001560293) (Filer)
42dPR
WallachBeth Capital Announces Closing of Tenon Medical, Inc Private Placement of Senior Original Issue Discount Convertible Notes Offering for Gross Proceeds of $4.3 Million
JERSEY CITY, N.J., March 12, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announces the closing of Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), private placement of senior convertible promissory notes with several institutional and high net worth investors for aggregate gross proceeds of $4.3 million before deducting fees of the placement agent. The 20% original issue discount notes have an aggregate principal amount of $4.3 million with a maturity date of September 11, 2026 and are con
42dNEWS
Tenon Medical Announces Closing of Private Placement of Senior Convertible Notes Offering for Gross Proceeds of $ 4.3 Million
LOS GATOS, CA / ACCESS Newswire / March 12, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorders, today announced the closing of a private placement of senior convertible promissory notes with several institutional and high net worth investors for aggregate gross proceeds of $4.3 million before deducting fees of the placement agent.The 20% original issue discount notes have an aggregate principal amount of $4.3 million with a maturity date of September 11, 2026 and are convertible, following the six month anniversary of the issuance date, into shares of the Company's common stock at a conve
49dINSIDER
Chief Financial Officer Williamson Kevin converted options into 1,041 shares, increasing direct ownership by 2% to 43,593 units (SEC Form 4)
4 - Tenon Medical, Inc. (0001560293) (Issuer)
55dSEC
Tenon Medical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8-K - Tenon Medical, Inc. (0001560293) (Filer)
64dNEWS
Tenon(R) Medical Strengthens Intellectual Property Portfolio with Strategic Patent Expansion
Expanded Global Portfolio Enhances Competitive Position and Supports Long-Term Growth StrategyLOS GATOS, CA / ACCESS Newswire / February 18, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients suffering from sacro-pelvic disorders, today announced a strategic expansion of its U.S. intellectual property portfolio following receipt of Notices of Allowance from the United States Patent and Trademark Office (USPTO) for multiple patent applications expected to issue in 2026. These newly allowed claims will further strengthen the Company's growing patent portfolio and build upon the (10) ten patents issued in 2025, including (5) five issued b
70dSEC
SEC Form S-8 filed by Tenon Medical Inc.
S-8 - Tenon Medical, Inc. (0001560293) (Filer)
76dSEC
Tenon Medical Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
8-K - Tenon Medical, Inc. (0001560293) (Filer)
77dNEWS
Tenon Medical, Inc. Sets Date for Fourth Quarter and Full Year 2025 Earnings, Reaffirms Expected Revenues
Fourth Quarter 2025 Revenue of $1.45 to $1.48 Million, representing growth of ~90% year over yearFull Year 2025 Revenue of $3.91 to $3.94 Million, representing growth of ~20% year over yearLOS GATOS, CA / ACCESS Newswire / February 5, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients suffering from sacro-pelvic disorders, today announced plans to release financial results for the fourth quarter and full year 2025 ended December 31, 2025 after market close on Thursday, March 19, 2026. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will
85dNEWS
Tenon(R) Medical Issues Shareholder Letter and Provides Preliminary Revenue for the Fourth Quarter and Full Year 2025
Fourth Quarter 2025 Revenue of $1.45 to $1.48 Million, representing growth of ~90% year over year.Full Year 2025 Revenue of $3.91 to $3.94 Million, representing growth of ~20% year over year.LOS GATOS, CA / ACCESS Newswire / January 28, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company redefining care for patients suffering from sacro-pelvic disorders, today issued a letter to shareholders from Steve Foster, President and Chief Executive Officer.Dear Fellow Shareholders,2025 was marked by strong commercial execution as we advanced innovation and expanded our differentiated solutions in the marketplace. We delivered both sequential and year over year revenue growt
108dINSIDER
CEO and President Foster Steven M converted options into 140,936 shares, increasing direct ownership by 616% to 163,814 units (SEC Form 4)
4 - Tenon Medical, Inc. (0001560293) (Issuer)
108dINSIDER
Director Hochschuler Stephen converted options into 10,732 shares and covered exercise/tax liability with 3,327 shares, increasing direct ownership by 1,389% to 7,938 units (SEC Form 4)
4 - Tenon Medical, Inc. (0001560293) (Issuer)
108dINSIDER
Director Weigle Robert K converted options into 10,732 shares and covered exercise/tax liability with 3,413 shares, increasing direct ownership by 3,141% to 7,552 units (SEC Form 4)
4 - Tenon Medical, Inc. (0001560293) (Issuer)
108dINSIDER
Chief Financial Officer Williamson Kevin converted options into 58,987 shares and covered exercise/tax liability with 18,518 shares, increasing direct ownership by 1,943% to 42,552 units (SEC Form 4)
4 - Tenon Medical, Inc. (0001560293) (Issuer)
108dINSIDER
Chief Technology Officer Ginn Richard converted options into 126,577 shares and covered exercise/tax liability with 47,426 shares, increasing direct ownership by 1,229% to 85,589 units (SEC Form 4)
4 - Tenon Medical, Inc. (0001560293) (Issuer)
108dINSIDER
Director Jacques Kristine M converted options into 10,729 shares (SEC Form 4)
4 - Tenon Medical, Inc. (0001560293) (Issuer)
108dINSIDER
Director Howard Ivan converted options into 10,732 shares and covered exercise/tax liability with 3,327 shares, increasing direct ownership by 701% to 8,462 units (SEC Form 4)
4 - Tenon Medical, Inc. (0001560293) (Issuer)
108dINSIDER
Director Ferrari Richard converted options into 64,478 shares, increasing direct ownership by 1,026% to 70,764 units (SEC Form 4)
4 - Tenon Medical, Inc. (0001560293) (Issuer)
115dINSIDER
Director Howard Ivan converted options into 156 shares, increasing direct ownership by 17% to 1,057 units (SEC Form 4)
4 - Tenon Medical, Inc. (0001560293) (Issuer)
115dINSIDER
Director Weigle Robert K converted options into 156 shares, increasing direct ownership by 203% to 233 units (SEC Form 4)
4 - Tenon Medical, Inc. (0001560293) (Issuer)
122dINSIDER
SEC Form 4 filed by Director Jacques Kristine M
4 - Tenon Medical, Inc. (0001560293) (Issuer)